Workflow
Guangdong Dtech Technology (301377)
icon
Search documents
鼎泰高科:关于增加使用部分暂时闲置募集资金进行现金管理的公告
2023-08-22 10:26
证券代码:301377 证券简称:鼎泰高科 公告编号:2023-041 广东鼎泰高科技术股份有限公司 关于增加使用部分暂时闲置募集资金进行现金管理的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 广东鼎泰高科技术股份有限公司(以下简称"公司")于 2023 年 8 月 22 日召开第一届董事会第十六次会议、第一届监事会第十五次会议,审议通过《关 于增加使用部分暂时闲置募集资金进行现金管理的议案》,同意公司在确保不影 响募集资金投资项目实施及募集资金安全的情况下,增加不超过 2 亿元闲置募集 资金(含超募资金)现金管理的额度,即公司使用闲置募集资金(含超募资金) 进行现金管理的额度由 5 亿元增加至 7 亿元。上述增加额度自公司董事会审议通 过之日起至 2023 年 11月 30 日有效,在前述额度和期限范围内可循环滚动使用。 暂时闲置募集资金(含超募资金)现金管理到期后将及时归还至募集资金专户。 现将有关事项公告如下: 一、募集资金基本情况 经中国证券监督管理委员会《关于同意广东鼎泰高科技术股份有限公司首次 公开发行股票注册的批复》(证监许可[2022] ...
鼎泰高科:监事会决议公告
2023-08-22 10:26
第一届监事会第十五次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 广东鼎泰高科技术股份有限公司(以下简称"公司")第一届监事会第十五 次会议于 2023 年 8 月 22 日在公司会议室以现场及通讯表决相结合的方式召开。 会议通知于 2023 年 8 月 11 日以电子邮件、电话或书面方式送达。本次监事会应 参加监事 3 人,实际参加监事 3 人,会议由公司监事会主席张勇先生召集并主 持。会议的召开符合《公司法》《公司章程》和《监事会议事规则》的有关规定。 一、监事会会议审议情况 证券代码:301377 证券简称:鼎泰高科 公告编号:2023-040 广东鼎泰高科技术股份有限公司 经过各位监事认真审议,本次会议形成如下决议: 1、审议通过《关于<2023 年半年度报告>全文及其摘要的议案》 监事会认为:董事会编制和审议公司《2023 年半年度报告》全文及其摘要的 程序符合法律、行政法规和中国证监会的规定,报告内容真实、准确、完整地反 映了上市公司实际情况,不存在任何虚假记载、误导性陈述或重大遗漏。 具体内容详见公司于巨潮资讯网(http://w ...
鼎泰高科:关于子公司为公司提供担保的进展公告
2023-08-15 11:06
证券代码:301377 证券简称:鼎泰高科 公告编号:2023-036 广东鼎泰高科技术股份有限公司 (一)基本情况 公司名称:广东鼎泰高科技术股份有限公司 统一社会信用代码:91441900076699698P 企业类型:其他股份有限公司(上市) 关于子公司为公司提供担保的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 一、担保情况概述 广东鼎泰高科技术股份有限公司(以下简称"公司"或"鼎泰高科")于 2023 年 4 月 14 日、2023 年 5 月 5 日分别召开了第一届董事会第十四次会议及 2022 年年度股东大会,审议通过了《关于向银行申请综合授信额度并提供担保 的议案》,同意公司及全资子公司广东鼎泰机器人科技有限公司(以下简称"鼎 泰机器人")、南阳鼎泰高科有限公司(以下简称"南阳鼎泰")、东莞市鼎泰 鑫电子有限公司向银行及其他金融机构申请额度不超过人民币 8 亿元的综合授 信额度,在上述综合授信额度内,公司及子公司为银行授信金额提供担保,合计 担保额度不超过人民币 8 亿元,担保额度可循环滚动使用。具体内容详见公司于 2023 年 4 ...
鼎泰高科(301377) - 2023年4月25日投资者关系活动记录表
2023-04-27 09:11
Group 1: Company Overview and Market Position - Guangdong Dingtai High-Tech Co., Ltd. is a leading company in the PCB drill needle market, holding a global market share of approximately 19% in 2020, ranking first in sales volume [4] - The company ranked first among specialized materials enterprises in the tool category according to the CPCA's 2021 report [4][5] - In 2022, drill needle products accounted for 69.65% of the company's total revenue [6] Group 2: Financial Performance and Goals - As of December 31, 2022, the company had utilized RMB 145.4572 million of its raised funds, with an unutilized amount of RMB 911.4605 million [4] - The company aims to enhance its operational scale for mature products and increase its market share in overseas markets [4] Group 3: Investment and Development Strategies - The company plans to establish a subsidiary in Thailand and invest in a production base to expand its international business and enhance competitiveness [5][7] - Continuous investment in R&D is emphasized to adapt to industry changes and seize new market opportunities [5][6] Group 4: Product and Technology Development - The company is focusing on optimizing product structure and enhancing market share through technological advancements [3][4] - It has developed intelligent manufacturing systems and visual inspection equipment to improve production efficiency and product traceability [7]
鼎泰高科(301377) - 2023 Q1 - 季度财报
2023-04-26 16:00
Financial Performance - The company's revenue for Q1 2023 was ¥276,259,014.61, a decrease of 5.90% compared to ¥293,580,401.99 in the same period last year[4] - Net profit attributable to shareholders increased by 17.52% to ¥68,258,019.82 from ¥58,081,493.86 year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥41,519,905.26, down 25.88% from ¥56,015,021.42 in the previous year[4] - Total operating revenue for Q1 2023 was CNY 276,259,014.61, a decrease of 5.5% compared to CNY 293,580,401.99 in Q1 2022[22] - Net profit for Q1 2023 reached CNY 68,214,720.44, an increase of 17.4% compared to CNY 58,045,660.66 in Q1 2022[23] - The total comprehensive income for the first quarter of 2023 was ¥68,214,720.44, an increase of 17.5% compared to ¥58,045,660.66 in the same period last year[24] Cash Flow and Liquidity - The company's cash flow from operating activities was ¥41,032,708.41, an increase of 15.20% compared to ¥35,619,723.47 in the same period last year[4] - Net cash flow from operating activities was ¥41,032,708.41, an increase of 15.5% compared to ¥35,619,723.47 in the same period last year[27] - Cash received from sales of goods and services was ¥230,531,684.45, down 5.4% from ¥242,862,349.43 in the previous year[26] - The ending balance of cash and cash equivalents was ¥575,275,515.14, down from ¥855,280,439.38 at the beginning of the period, reflecting a decrease of 32.7%[27] - The company reported a net increase in cash and cash equivalents of -¥280,004,924.24 for the quarter, contrasting with an increase of ¥42,508,281.41 in the same period last year[27] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,897,467,882.61, a decrease of 1.31% from ¥2,935,960,687.11 at the end of the previous year[4] - Total liabilities decreased to CNY 639,777,047.15 in Q1 2023 from CNY 746,484,572.09 in Q1 2022, a reduction of 14.3%[20] - Cash and cash equivalents decreased by 31.96% to ¥586,447,004.37 from ¥861,968,576.43 at the end of the previous year[8] - Accounts receivable decreased to ¥422,256,073.28 from ¥447,985,637.22, indicating a reduction of about 5.8%[18] Shareholder Information - The company reported a total of 10 major shareholders, with the largest being Ping An Fund holding 2,849,798 shares, accounting for 0.70% of total shares[16] - The second largest shareholder, China Industrial Bank, holds 769,863 shares, representing 0.19% of total shares[16] - The company has a total of 86.82% of shares controlled by its actual controllers through various partnerships and direct holdings[16] Investment and Development - The company reported a significant increase in government subsidies, totaling ¥31,312,443.09, up 1148.30% from ¥2,508,406.37 in the previous year[11] - The company experienced a 241.24% increase in net cash flow from investing activities, amounting to -¥261,593,579.31 compared to -¥76,659,924.84 in the previous year[13] - Research and development expenses for Q1 2023 amounted to CNY 22,696,582.34, up from CNY 18,634,960.97 in Q1 2022, indicating a growth of 21.8%[23] - The company plans to continue investing in new product development and market expansion strategies to drive future growth[23] Future Outlook - Future guidance indicates a cautious outlook due to market conditions, with a focus on maintaining liquidity and managing operational costs[17] - The company is focusing on expanding its market presence and developing new technologies, although specific figures were not disclosed in the report[17] - The company is exploring potential mergers and acquisitions to enhance its market position, although no specific targets were mentioned[17] Earnings and Ratios - The company's basic earnings per share rose by 6.25% to ¥0.17 from ¥0.16 in the same period last year[4] - The weighted average return on equity decreased by 3.05% to 3.07% from 6.12% year-on-year[4] - Basic and diluted earnings per share for the first quarter were both ¥0.17, up from ¥0.16 in the previous year, reflecting a growth of 6.25%[24]
鼎泰高科(301377) - 2022 Q4 - 年度财报
2023-04-14 16:00
Dividend and Profit Distribution - The company plans to distribute a cash dividend of 0.7 RMB per 10 shares to all shareholders, based on a total of 410,000,000 shares[3]. - The proposed cash dividend is set at 0.7 RMB per 10 shares, totaling 28,700,000 RMB, which represents 20.16% of the distributable profits[160]. - The total distributable profits for the year amount to 142,331,907.73 RMB[160]. - The company emphasizes a profit distribution policy that combines stable cash dividends and stock dividends, considering the interests of shareholders[154]. - The company plans to distribute at least 10% of the annual distributable profits as cash dividends after reserving sufficient surplus funds[157]. - In the current growth phase with significant capital expenditure, the cash dividend proportion must reach at least 20% of the total profit distribution[159]. - The cash dividend policy is aligned with the company's articles of association and shareholder resolutions[160]. - The company has no stock bonus or capital reserve increase planned for this distribution[162]. Financial Performance - The company's operating revenue for 2022 was ¥1,218,646,786.77, a decrease of 0.31% compared to ¥1,222,446,649.04 in 2021[19]. - The net profit attributable to shareholders for 2022 was ¥222,817,821.83, down 6.25% from ¥237,675,152.08 in 2021[19]. - The net cash flow from operating activities decreased by 34.25% to ¥156,128,000.06 in 2022 from ¥237,464,242.96 in 2021[19]. - The total assets at the end of 2022 increased by 59.95% to ¥2,935,960,687.11 from ¥1,835,537,167.43 at the end of 2021[19]. - The company's basic earnings per share for 2022 was ¥0.61, a decrease of 7.58% compared to ¥0.66 in 2021[19]. - The weighted average return on equity for 2022 was 19.93%, down from 29.68% in 2021, reflecting a decline of 9.75%[19]. - The company achieved a first-pass yield of over 85% for grinding drill needles, with a secondary repair yield reaching 95%[59]. - The gross margin improved to 35% in 2022, up from 30% in 2021, reflecting better cost management and pricing strategies[126]. Market and Industry Position - The company holds a 19% market share in global PCB drill sales, ranking first in the industry[35]. - The company operates in the "C33 Metal Products Industry" and focuses on manufacturing cutting tools for PCB processing, which is supported by national industrial policies[29]. - The PCB industry, a key component of the electronic information industry, is expected to grow, positively impacting the company's future operations[30]. - The company is focusing on optimizing product structure and expanding market reach in response to emerging demands in sectors like telecommunications, cloud computing, and automotive electronics[42]. - The company is actively investing in R&D to adapt to industry changes and enhance product offerings[41]. - The PCB cutting tool industry faces increasing competition, and the company must continuously invest in production process improvements and talent acquisition to maintain its market position[92]. Research and Development - The company has developed 247 patents, including 19 invention patents, enhancing its competitive edge in precision manufacturing[38]. - R&D investment amounted to ¥79,816,924.11 in 2022, representing 6.55% of total revenue, an increase from 6.04% in 2021[60]. - Research and development investments increased by 30% in 2022, totaling 150 million RMB, to enhance product innovation[128]. - The company is investing 100 million RMB in R&D for new technologies aimed at enhancing product efficiency[191]. - The company is exploring potential acquisitions to strengthen its supply chain, with a budget of 500 million RMB allocated for this purpose in 2023[123]. Corporate Governance and Compliance - The financial report is guaranteed to be true, accurate, and complete by the company's management, including the CEO and accounting head[3]. - The company has established a robust internal audit system to enhance governance and compliance with relevant laws and regulations[104]. - The company adheres to strict compliance with laws and regulations to protect shareholder rights and enhance corporate governance[173]. - The company has established multiple communication channels to address employee concerns and improve satisfaction[175]. - The company has a comprehensive internal control system that is regularly updated to align with legal requirements[173]. Future Outlook and Strategic Initiatives - The company provided a positive outlook for 2023, projecting a revenue growth of 25% and aiming to reach 1.875 billion RMB[125]. - New product launches are expected to contribute an additional 300 million RMB in revenue in 2023, focusing on innovative electronic materials[126]. - The company plans to enhance its digital marketing efforts, aiming for a 20% increase in online sales channels by the end of 2023[125]. - The company plans to implement a share buyback program within 2 months after the announcement of the plan[197]. - The company aims to maintain stock price stability through various measures, including potential stock buybacks and shareholder communication[193]. Environmental and Social Responsibility - The company has implemented measures to reduce carbon emissions, including wastewater treatment and air pollution control systems[172]. - The company emphasizes a green development philosophy, prioritizing environmental friendliness in its operations and production processes[176]. - The company has actively participated in poverty alleviation initiatives, contributing to the "Thousand Enterprises Helping Thousand Villages" campaign[178]. - The company has committed to reducing carbon emissions by phasing out outdated high-energy-consuming equipment and expanding the use of clean energy[176]. Employee and Management Practices - The total number of employees at the end of the reporting period was 2,831, with 1,757 in production, 743 in technical roles, and 68 in sales[150]. - The company has established a competitive compensation system, ensuring employee income is strong relative to regional and industry standards[151]. - The training program includes diverse learning methods such as classroom teaching, online training, and external training to enhance employee skills and organizational performance[152]. - The company will implement a talent development plan to attract and retain skilled management and operational personnel[88].
鼎泰高科:关于举行2022年度业绩说明会的公告
2023-04-14 13:24
证券代码:301377 证券简称:鼎泰高科 公告编号:2023-014 (问题征集专题页面二维码) 特此公告。 广东鼎泰高科技术股份有限公司 董事会 2023 年 4 月 14 日 广东鼎泰高科技术股份有限公司 关于举行2022年度业绩说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 广东鼎泰高科技术股份有限公司(以下简称"公司")《2022 年年度报告》 全文及《2022 年年度报告摘要》已于 2023 年 4 月 15 日在巨潮资讯网 (http://www.cninfo.com.cn)披露。为便于投资者能够进一步了解公司的生产经 营情况,公司将于 2023 年 4 月 25 日(星期二)下午 15:00-17:00 在全景网举办 2022 年度网上业绩说明会。本次年度业绩说明会将采用网络远程的方式举行, 投资者可登陆"全景•路演天下"(http://rs.p5w.net)参与本次年度业绩说明会。 出席本次年度业绩说明会的人员有:公司董事长兼总经理王馨女士、独立董 事李小菲女士、财务总监徐辉先生、副总经理兼董事会秘书周文英女士和保荐代 表人万俊 ...